192 related articles for article (PubMed ID: 29727577)
1. Carrier-Free, Pure Nanodrug Formed by the Self-Assembly of an Anticancer Drug for Cancer Immune Therapy.
Fan L; Zhang B; Xu A; Shen Z; Guo Y; Zhao R; Yao H; Shao JW
Mol Pharm; 2018 Jun; 15(6):2466-2478. PubMed ID: 29727577
[TBL] [Abstract][Full Text] [Related]
2. A Carrier-Free Folate Receptor-Targeted Ursolic Acid/Methotrexate Nanodelivery System for Synergetic Anticancer Therapy.
Lan JS; Qin YH; Liu L; Zeng RF; Yang Y; Wang K; Ding Y; Zhang T; Ho RJY
Int J Nanomedicine; 2021; 16():1775-1787. PubMed ID: 33692622
[TBL] [Abstract][Full Text] [Related]
3. Carrier-free nanodrug by co-assembly of chemotherapeutic agent and photosensitizer for cancer imaging and chemo-photo combination therapy.
Zhao R; Zheng G; Fan L; Shen Z; Jiang K; Guo Y; Shao JW
Acta Biomater; 2018 Apr; 70():197-210. PubMed ID: 29408311
[TBL] [Abstract][Full Text] [Related]
4. Ursolic acid-loaded chitosan nanoparticles induce potent anti-angiogenesis in tumor.
Jin H; Pi J; Yang F; Wu C; Cheng X; Bai H; Huang D; Jiang J; Cai J; Chen ZW
Appl Microbiol Biotechnol; 2016 Aug; 100(15):6643-6652. PubMed ID: 26883344
[TBL] [Abstract][Full Text] [Related]
5. Delivery of ursolic acid (UA) in polymeric nanoparticles effectively promotes the apoptosis of gastric cancer cells through enhanced inhibition of cyclooxygenase 2 (COX-2).
Zhang H; Li X; Ding J; Xu H; Dai X; Hou Z; Zhang K; Sun K; Sun W
Int J Pharm; 2013 Jan; 441(1-2):261-8. PubMed ID: 23194884
[TBL] [Abstract][Full Text] [Related]
6. A self-assembly nanodrug delivery system based on amphiphilic low generations of PAMAM dendrimers-ursolic acid conjugate modified by lactobionic acid for HCC targeting therapy.
Shen Z; Li B; Liu Y; Zheng G; Guo Y; Zhao R; Jiang K; Fan L; Shao J
Nanomedicine; 2018 Feb; 14(2):227-236. PubMed ID: 29128661
[TBL] [Abstract][Full Text] [Related]
7. Reducing PD-L1 expression with a self-assembled nanodrug: an alternative to PD-L1 antibody for enhanced chemo-immunotherapy.
Cai S; Chen Z; Wang Y; Wang M; Wu J; Tong Y; Chen L; Lu C; Yang H
Theranostics; 2021; 11(4):1970-1981. PubMed ID: 33408792
[TBL] [Abstract][Full Text] [Related]
8. Folate-Chitosan Nanoparticles Loaded with Ursolic Acid Confer Anti-Breast Cancer Activities in vitro and in vivo.
Jin H; Pi J; Yang F; Jiang J; Wang X; Bai H; Shao M; Huang L; Zhu H; Yang P; Li L; Li T; Cai J; Chen ZW
Sci Rep; 2016 Jul; 6():30782. PubMed ID: 27469490
[TBL] [Abstract][Full Text] [Related]
9. Ursolic acid derivative UA232 evokes apoptosis of lung cancer cells induced by endoplasmic reticulum stress.
Gou W; Luo N; Wei H; Wu H; Yu X; Duan Y; Bi C; Ning H; Hou W; Li Y
Pharm Biol; 2020 Dec; 58(1):707-715. PubMed ID: 32726164
[TBL] [Abstract][Full Text] [Related]
10. pH-Sensitive mesoporous silica nanoparticles anticancer prodrugs for sustained release of ursolic acid and the enhanced anti-cancer efficacy for hepatocellular carcinoma cancer.
Li T; Chen X; Liu Y; Fan L; Lin L; Xu Y; Chen S; Shao J
Eur J Pharm Sci; 2017 Jan; 96():456-463. PubMed ID: 27771513
[TBL] [Abstract][Full Text] [Related]
11. Ursolic Acid Loaded PLGA Nanoparticles: in vitro and in vivo Evaluation to Explore Tumor Targeting Ability on B16F10 Melanoma Cell Lines.
Baishya R; Nayak DK; Kumar D; Sinha S; Gupta A; Ganguly S; Debnath MC
Pharm Res; 2016 Nov; 33(11):2691-703. PubMed ID: 27431865
[TBL] [Abstract][Full Text] [Related]
12. A smart pH-responsive nano-carrier as a drug delivery system for the targeted delivery of ursolic acid: suppresses cancer growth and metastasis by modulating P53/MMP-9/PTEN/CD44 mediated multiple signaling pathways.
Jiang K; Chi T; Li T; Zheng G; Fan L; Liu Y; Chen X; Chen S; Jia L; Shao J
Nanoscale; 2017 Jul; 9(27):9428-9439. PubMed ID: 28660943
[TBL] [Abstract][Full Text] [Related]
13. Ursolic acid nanoparticles inhibit cervical cancer growth in vitro and in vivo via apoptosis induction.
Wang S; Meng X; Dong Y
Int J Oncol; 2017 Apr; 50(4):1330-1340. PubMed ID: 28259944
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo antitumor effects of folate-targeted ursolic acid stealth liposome.
Yang G; Yang T; Zhang W; Lu M; Ma X; Xiang G
J Agric Food Chem; 2014 Mar; 62(10):2207-15. PubMed ID: 24528163
[TBL] [Abstract][Full Text] [Related]
15. Efficient delivery of ursolic acid by poly(N-vinylpyrrolidone)-block-poly (ε-caprolactone) nanoparticles for inhibiting the growth of hepatocellular carcinoma in vitro and in vivo.
Zhang H; Zheng D; Ding J; Xu H; Li X; Sun W
Int J Nanomedicine; 2015; 10():1909-20. PubMed ID: 25792825
[TBL] [Abstract][Full Text] [Related]
16. Small Molecule Nanodrug Assembled of Dual-Anticancer Drug Conjugate for Synergetic Cancer Metastasis Therapy.
Li C; Lin J; Wu P; Zhao R; Zou J; Zhou M; Jia L; Shao J
Bioconjug Chem; 2018 Oct; 29(10):3495-3502. PubMed ID: 30252441
[TBL] [Abstract][Full Text] [Related]
17. Advances in the Anticancer Value of the Ursolic Acid Through Nanodelivery.
Manayi A; Nikan M; Nobakht-Haghighi N; Abdollahi M
Curr Med Chem; 2018; 25(37):4866-4875. PubMed ID: 28707589
[TBL] [Abstract][Full Text] [Related]
18. Dual stimuli-responsive ursolic acid-embedded nanophytoliposome for targeted antitumor therapy.
Poudel K; Gautam M; Maharjan S; Jeong JH; Choi HG; Khan GM; Yong CS; Kim JO
Int J Pharm; 2020 May; 582():119330. PubMed ID: 32298743
[TBL] [Abstract][Full Text] [Related]
19. Ursolic acid inhibits colorectal cancer angiogenesis through suppression of multiple signaling pathways.
Lin J; Chen Y; Wei L; Hong Z; Sferra TJ; Peng J
Int J Oncol; 2013 Nov; 43(5):1666-74. PubMed ID: 24042330
[TBL] [Abstract][Full Text] [Related]
20. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.
Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W
Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]